Richard M Van Rijn (Richard M van Rijn)

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 22

Top Venues

Journal of medicinal chemistry

Molecules (Basel, Switzerland)

Science signaling

Headache

Purdue University

VU University Amsterdam (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Purdue University Aug 12 2019

United States

Associate Professor :: Medicinal Chemistry and Molecular Pharmacology

Purdue University Sep 15 2013 - Aug 11 2019

United States

Assistant Professor :: Medicinal Chemistry and Molecular Pharmacology

Ernest Gallo Clinic and Research Center Sep 01 2011 - Sep 14 2013

United States

Associate Research Scientist :: Neurology

Ernest Gallo Clinic and Research Center Jan 01 2011 - Aug 31 2011

United States

Assistant Research Scientist :: Neurology

Ernest Gallo Clinic and Research Center Jan 09 2007 - Dec 31 2010

United States

Postdoctoral fellow :: Neurology

BioFocus DPI BV Jun 01 2006 - Dec 31 2006

Netherlands

Research associate

Education History

VU University Amsterdam May 01 2002 - May 31 2006

Netherlands

PHD :: Chemistry and Pharmaceutical Sciences

Publications

Madeline R Hennessy, Anna M Gutridge, Alexander R French, Elizabeth S Rhoda, Yazan J Meqbil, Meghna Gill, Yavnika Kashyap, Kevin Appourchaux, Barnali Paul, Zaijie Jim Wang, Richard M Van Rijn, Andrew P Riley
Modified Akuamma Alkaloids with Increased Potency at the Mu-opioid Receptor. Journal of medicinal chemistry 66 (5) (2023)
Madeline R Hennessy, Anna M Gutridge, Alexander R French, Elizabeth S Rhoda, Yazan J Meqbil, Meghna Gill, Yavnika Kashyap, Kevin Appourchaux, Barnali Paul, Zaijie Jim Wang, Richard M Van Rijn, Andrew P Riley
Modified Akuamma Alkaloids with Increased Potency at the Mu-opioid Receptor. Journal of medicinal chemistry 66 (5) (2023)
Madeline R Hennessy, Anna M Gutridge, Alexander R French, Elizabeth S Rhoda, Yazan J Meqbil, Meghna Gill, Yavnika Kashyap, Kevin Appourchaux, Barnali Paul, Zaijie Jim Wang, Richard M Van Rijn, Andrew P Riley
Modified Akuamma Alkaloids with Increased Potency at the Mu-opioid Receptor. Journal of medicinal chemistry (2023)
Madeline R Hennessy, Anna M Gutridge, Alexander R French, Elizabeth S Rhoda, Yazan J Meqbil, Meghna Gill, Yavnika Kashyap, Kevin Appourchaux, Barnali Paul, Zaijie Jim Wang, Richard M Van Rijn, Andrew P Riley
Modified Akuamma Alkaloids with Increased Potency at the Mu-opioid Receptor. Journal of medicinal chemistry 66 (5) (2023)
Madeline R Hennessy, Anna M Gutridge, Alexander R French, Elizabeth S Rhoda, Yazan J Meqbil, Meghna Gill, Yavnika Kashyap, Kevin Appourchaux, Barnali Paul, Zaijie Jim Wang, Richard M Van Rijn, Andrew P Riley
Modified Akuamma Alkaloids with Increased Potency at the Mu-opioid Receptor. Journal of medicinal chemistry 66 (5) (2023)
Madeline R Hennessy, Anna M Gutridge, Alexander R French, Elizabeth S Rhoda, Yazan J Meqbil, Meghna Gill, Yavnika Kashyap, Kevin Appourchaux, Barnali Paul, Zaijie Jim Wang, Richard M Van Rijn, Andrew P Riley
Modified Akuamma Alkaloids with Increased Potency at the Mu-opioid Receptor. Journal of medicinal chemistry 66 (5) (2023)
Madeline R Hennessy, Anna M Gutridge, Alexander R French, Elizabeth S Rhoda, Yazan J Meqbil, Meghna Gill, Yavnika Kashyap, Kevin Appourchaux, Barnali Paul, Zaijie Jim Wang, Richard M Van Rijn, Andrew P Riley
Modified Akuamma Alkaloids with Increased Potency at the Mu-opioid Receptor. Journal of medicinal chemistry 66 (5) (2023)
Luke L Liu, Richard M Van Rijn, Wei Zheng
Copper Modulates Adult Neurogenesis in Brain Subventricular Zone. International journal of molecular sciences 23 (17) (2022)
Yazan J Meqbil, Richard M Van Rijn
Opportunities and Challenges for In Silico Drug Discovery at Delta Opioid Receptors. Pharmaceuticals (Basel, Switzerland) 15 (7) (2022)
Richard M Van Rijn, Mariana Spetea
Opioids and Their Receptors: Present and Emerging Concepts in Opioid Drug Discovery II. Molecules (Basel, Switzerland) 27 (10) (2022)
Soumen Chakraborty, Jeffrey F DiBerto, Abdelfattah Faouzi, Sarah M Bernhard, Anna M Gutridge, Steven Ramsey, Yuchen Zhou, Davide Provasi, Nitin Nuthikattu, Rahul Jilakara, Melissa N F Nelson, Wesley B Asher, Shainnel O Eans, Lisa L Wilson, Satyanarayana M Chintala, Marta Filizola, Richard M Van Rijn, Elyssa B Margolis, Bryan L Roth, Jay P McLaughlin, Tao Che, Dalibor Sames, Jonathan A Javitch, Susruta Majumdar
A Novel Mitragynine Analog with Low-Efficacy Mu Opioid Receptor Agonism Displays Antinociception with Attenuated Adverse Effects. Journal of medicinal chemistry 64 (18) (2021)
Mee Jung Ko, Terrance Chiang, Arbaaz A Mukadam, Grace E Mulia, Anna M Gutridge, Angel Lin, Julia A Chester, Richard M Van Rijn
β-Arrestin-dependent ERK signaling reduces anxiety-like and conditioned fear-related behaviors in mice. Science signaling 14 (694) (2021)
Yazan J Meqbil, Hongyu Su, Robert J Cassell, Kendall L Mores, Anna M Gutridge, Benjamin R Cummins, Lan Chen, Richard M Van Rijn
Identification of a Novel Delta Opioid Receptor Agonist Chemotype with Potential Negative Allosteric Modulator Capabilities. Molecules (Basel, Switzerland) 26 (23) (2021)
Krishna K Sharma, Robert J Cassell, Yazan J Meqbil, Hongyu Su, Arryn T Blaine, Benjamin R Cummins, Kendall L Mores, David K Johnson, Richard M Van Rijn, Ryan A Altman
Modulating β-arrestin 2 recruitment at the δ- and μ-opioid receptors using peptidomimetic ligands. RSC medicinal chemistry 12 (11) (2021)
Zachariah Bertels, Wiktor D Witkowski, Sarah Asif, Kendra Siegersma, Richard M Van Rijn, Amynah Amir Ali Pradhan
A non-convulsant delta-opioid receptor agonist, KNT-127, reduces cortical spreading depression and nitroglycerin-induced allodynia. Headache 61 (1) (2020)
Simone M Creed, Anna M Gutridge, Malaika D Argade, Madeline R Hennessy, John Brent Friesen, Guido F Pauli, Richard M Van Rijn, Andrew P Riley
Isolation and Pharmacological Characterization of Six Opioidergic Picralima nitida Alkaloids. Journal of natural products 84 (1) (2020)
Anna M Gutridge, Meridith T Robins, Robert J Cassell, Rajendra Uprety, Kendall L Mores, Mee Jung Ko, Gavril W Pasternak, Susruta Majumdar, Richard M Van Rijn
G protein-biased kratom-alkaloids and synthetic carfentanil-amide opioids as potential treatments for alcohol use disorder. British journal of pharmacology 177 (7) (2020)
Bo Cai, Dongwook Kim, Saeed Akhand, Yixing Sun, Robert J Cassell, Aktan Alpsoy, Emily C Dykhuizen, Richard M Van Rijn, Michael K Wendt, Casey J Krusemark
Selection of DNA-Encoded Libraries to Protein Targets within and on Living Cells. Journal of the American Chemical Society 141 (43) (2019)
Robert J Cassell, Krishna K Sharma, Hongyu Su, Benjamin R Cummins, Haoyue Cui, Kendall L Mores, Arryn T Blaine, Ryan A Altman, Richard M Van Rijn
The Meta-Position of Phe4 in Leu-Enkephalin Regulates Potency, Selectivity, Functional Activity, and Signaling Bias at the Delta and Mu Opioid Receptors. Molecules (Basel, Switzerland) 24 (24) (2019)
Mee Jung Ko, Logan C Ganzen, Emre Coskun, Arbaaz A Mukadam, Yuk Fai Leung, Richard M Van Rijn
A critical evaluation of TRPA1-mediated locomotor behavior in zebrafish as a screening tool for novel anti-nociceptive drug discovery. Scientific reports 9 (1) (2019)
Tarsis F Brust, Doungkamol Alongkronrusmee, Monica Soto-Velasquez, Tanya A Baldwin, Zhi-Shi Ye, Mingji Dai, Carmen W Dessauer, Richard M Van Rijn, Val J Watts
Identification of a selective small-molecule inhibitor of type 1 adenylyl cyclase activity with analgesic properties. Science signaling 10 (467) (2017)
Meridith T Robins, Julie Lu, Richard M Van Rijn
Unique Behavioral and Neurochemical Effects Induced by Repeated Adolescent Consumption of Caffeine-Mixed Alcohol in C57BL/6 Mice. PloS one 11 (7) (2016)

Richard M Van Rijn.css-eqlu8i{font-size:small;padding-left:4px;} (Richard M van Rijn)

Publication Activity (10 Years)

Top Topics

Top Venues

Richard M Van Rijn (Richard M van Rijn)